Curis to Present at the Brean Murray & Co. Annual Institutional Investor Conference
Wednesday January 26, 8:30 am ET
CAMBRIDGE, Mass.--(BUSINESS WIRE)--Jan. 26, 2005--Curis, Inc. (NASDAQ: CRIS - News) announced today that Daniel Passeri, Curis' President and Chief Executive Officer, will present an overview of the status of Curis' business at the upcoming Brean Murray & Co. Annual Institutional Investor Conference on February 2 at The New York Palace Hotel in New York City. Mr. Passeri's presentation will be at 4:30 p.m. EST in the Villard Room.
The presentation will be webcast live at:
www.corporate-ir.net/ireye/confLobby.zhtml?ticker=CRIS&item_id=986496
It will be archived for 30 days following the conference. The presentation will also be available on the Investor Relations section of Curis' website at www.curis.com.
About Curis, Inc.
Curis, Inc. is a therapeutic drug development company. The Company's technology focus is on regulatory pathways that control repair and regeneration. Curis' product development involves the use of proteins or small molecules to modulate these pathways. Curis has successfully used this technology and product development approach to produce several promising drug product candidates in the fields of kidney disease (partnered with Ortho Biotech, a subsidiary of Johnson & Johnson), cancer (partnered with Genentech), neurological disorders (partnered with Wyeth Pharmaceuticals), alopecia, and cardiovascular disease. For more information, please visit the Curis web site at www.curis.com. |
